Evidence map›Paper›PMID 36498953›Full record

ArticleInternational journal of molecular sciences2022

Fermented

Jia-Wei Shen, Po-Yuan Wu, Yueh-Hsiung Kuo, Qiao-Xin Chang, Kuo-Ching Wen, Hsiu-Mei Chiang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Pivotal Role of mTOR in Non-Skin Manifestations of Psoriasis.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jia-Wei ShenDepartment of Cosmeceutics, China Medical University, Taichung 406, Taiwan.ORCID 0000-0002-2568-4512
Po-Yuan WuDepartment of Dermatology, China Medical University Hospital, Taichung 404, Taiwan.ORCID 0000-0003-0264-2536
Yueh-Hsiung KuoDepartment of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan.ORCID 0000-0001-5935-6755
Qiao-Xin ChangDepartment of Cosmeceutics, China Medical University, Taichung 406, Taiwan.
Kuo-Ching WenDepartment of Cosmeceutics, China Medical University, Taichung 406, Taiwan.
Hsiu-Mei ChiangDepartment of Cosmeceutics, China Medical University, Taichung 406, Taiwan.ORCID 0000-0002-1586-910X
China Medical University · TWAsia University · TW

Funding

China Medical University CMU106-ASIA-20China Medical University CMU109-MF-81the Ministry of Science and Technology MOST 110-2320-B-039-051-MY3
6 · The paper itself

Abstract

Psoriasis is a chronic autoimmune disease, and until now, it remains an incurable disease. Therefore, the development of new drugs or agents that ameliorate the disease will have marketing potential.

Indexed as

Biological ProductsKeratinocytesPsoriasisAnti-Inflammatory AgentsHaCaT CellsHumansInterleukin-17NF-kappa BPolyporalesTOR Serine-Threonine KinasesAnti-Inflammatory AgentsBiological ProductsInterleukin-17MTOR protein, humanNF-kappa BTOR Serine-Threonine KinasesIL-17Amammalian target of rapamycinnuclear factor kappa BpsoriasisTaiwanofungus camphoratus

Identifiers

PMID36498953
PMCPMC9739991
OpenAlexW4310036540

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.